We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGEE icon
4676
MGE Energy Inc
MGEE
$3.09B
$1.63M ﹤0.01%
22,338
+16,083
+257% +$1.11M
VRNT
4677
CALL
DELISTED
Verint Systems
VRNT
$1.63M ﹤0.01%
59,479
+1,178
+2% +$35.4K
BTEC
4678
DELISTED
Principal Exchange-Traded Funds Principal Healthcare Innovators ETF
BTEC
$1.63M ﹤0.01%
47,946
+31,780
+197% +$1.05M
FLXN
4679
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.63M ﹤0.01%
132,558
-178,352
-57% -$2.06M
DOVA
4680
PUT
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$1.63M ﹤0.01%
+115,500
New +$1.1M
FMBI
4681
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$1.63M ﹤0.01%
79,511
+56,342
+243% +$1.17M
FDIS icon
4682
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.72B
$1.63M ﹤0.01%
35,602
-4,705
-12% -$212K
MXIM
4683
PUT
DELISTED
Maxim Integrated Products
MXIM
$1.63M ﹤0.01%
27,200
+13,300
+96% +$758K
RLI icon
4684
RLI Corp
RLI
$5.85B
$1.63M ﹤0.01%
+37,940
New +$1.56M
AIMT
4685
PUT
DELISTED
Aimmune Therapeutics
AIMT
$1.63M ﹤0.01%
78,100
+39,400
+102% +$811K
BCS icon
4686
PUT
Barclays
BCS
$94.7B
$1.63M ﹤0.01%
218,106
+34,717
+19% +$274K
DESP
4687
DELISTED
Despegar.com
DESP
$1.63M ﹤0.01%
116,994
-19,779
-14% -$270K
JKS
4688
JinkoSolar
JKS
$877M
$1.63M ﹤0.01%
74,925
+54,096
+260% +$1.09M
VCYT icon
4689
Veracyte
VCYT
$3.32B
$1.63M ﹤0.01%
56,993
-152,776
-73% -$3.82M
WTI icon
4690
W&T Offshore
WTI
$554M
$1.63M ﹤0.01%
327,758
-724,054
-69% -$3.9M
FLO icon
4691
Flowers Foods
FLO
$1.59B
$1.62M ﹤0.01%
69,798
+46,222
+196% +$1.02M
PACW
4692
CALL
DELISTED
PacWest Bancorp
PACW
$1.62M ﹤0.01%
41,800
+9,800
+31% +$379K
CLB icon
4693
CALL
Core Laboratories
CLB
$571M
$1.62M ﹤0.01%
31,000
-20,900
-40% -$1.23M
CPF icon
4694
Central Pacific Financial
CPF
$996M
$1.62M ﹤0.01%
54,015
+33,537
+164% +$978K
RXI icon
4695
iShares Global Consumer Discretionary ETF
RXI
$274M
$1.62M ﹤0.01%
13,662
+6,151
+82% +$718K
ANSS
4696
PUT
DELISTED
Ansys
ANSS
$1.62M ﹤0.01%
7,900
-26,600
-77% -$5.07M
IAT icon
4697
CALL
iShares US Regional Banks ETF
IAT
$693M
$1.62M ﹤0.01%
35,200
+22,200
+171% +$1.01M
PRAH
4698
PUT
DELISTED
PRA Health Sciences, Inc.
PRAH
$1.62M ﹤0.01%
16,300
-7,700
-32% -$735K
PEGI
4699
PUT
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$1.62M ﹤0.01%
70,000
-24,200
-26% -$542K
BNDW icon
4700
Vanguard Total World Bond ETF
BNDW
$1.89B
$1.61M ﹤0.01%
20,487
+1,052
+5% +$81.2K

Similar funds

Citadel Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Citadel Advisors held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Citadel Advisors's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Citadel Advisors added most to Netflix in Q2 2019, an estimated $400M increase.
  • Citadel Advisors's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Citadel Advisors fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Citadel Advisors's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Citadel Advisors opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Citadel Advisors's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.